


The fund aims to produce a rising income with capital growth from a portfolio primarily made up of investments in the UK including ordinary shares, convertibles and fixed interest securities.
| Name | % Net Assets |
|---|---|
| BP | 5.0% |
| HSBC | 4.9% |
| GlaxoSmithKline | 4.5% |
| Vodafone | 3.3% |
| Royal Dutch Shell 'B' | 3.2% |
| Legal & General Group | 3.1% |
| Rio Tinto | 3.1% |
| BT | 2.9% |
| Reed Elsevier | 2.8% |
| Centrica | 2.5% |
| Key | % Net Assets |
|---|---|
| 5.0% | |
| 4.9% | |
| 4.5% | |
| 3.3% | |
| 82.3% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 708.49p |
| Currency | GBP |
| Change | 3.06p |
| % | 0.43% |
| YTD change | 90.47p |
| YTD % | 14.64% |
| Fund Inception | 06/06/2000 |
|---|---|
| Fund Manager | Adrian Frost / Adrian Gosden |
| TER | 1.55 (31-May-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £1,000 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.16 |
You are here: research